Detalles de la búsqueda
1.
Susceptibility of Melanoma Cells to Targeted Therapy Correlates with Protection by Blood Neutrophils.
Cancers (Basel)
; 16(9)2024 May 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38730718
2.
TERT expression is associated with metastasis from thin primaries, exhausted CD4+ T cells in melanoma and with DNA repair across cancer entities.
PLoS One
; 18(7): e0281487, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37418389
3.
Correlation of tumor PD-L1 expression in different tissue types and outcome of PD-1-based immunotherapy in metastatic melanoma - analysis of the DeCOG prospective multicenter cohort study ADOREG/TRIM.
EBioMedicine
; 96: 104774, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37660535
4.
Immune checkpoint inhibition in patients with NRAS mutated and NRAS wild type melanoma: a multicenter Dermatologic Cooperative Oncology Group study on 637 patients from the prospective skin cancer registry ADOREG.
Eur J Cancer
; 188: 140-151, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37245442
5.
Blood Eosinophils Are Associated with Efficacy of Targeted Therapy in Patients with Advanced Melanoma.
Cancers (Basel)
; 14(9)2022 May 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35565423
6.
MAPKinase inhibition after failure of immune checkpoint blockade in patients with advanced melanoma - An evaluation of the multicenter prospective skin cancer registry ADOREG.
Eur J Cancer
; 167: 32-41, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35366571
7.
Efficacy of PD-1-based immunotherapy after radiologic progression on targeted therapy in stage IV melanoma.
Eur J Cancer
; 116: 207-215, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31212163
8.
Patterns of disease control and survival in patients with melanoma brain metastases undergoing immune-checkpoint blockade.
Eur J Cancer
; 99: 58-65, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29906735
Resultados
1 -
8
de 8
1
Próxima >
>>